# OnCo record illuccix (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/illuccix/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "illuccix" ;
  schema:name "Illuccix (kit for Ga-68 gozetotide)"@en ;
  schema:description "Telix's ready-to-label kit that lets any nuclear medicine department make the gallium PSMA scan for prostate cancer."@en ;
  schema:url <https://onco.cc/drugs/illuccix/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamaoncol.2021.3771>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d4643b31-9b4f-673f-e053-2a95a90a559d> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "PET imaging agent kit (PSMA, gallium-68)" ;
  schema:alternateName "Illuccix / Gozellix" ;
  onco:approval "US 2021: PSMA PET imaging in prostate cancer (initial staging with suspected metastasis; suspected recurrence)", "Australia 2021: PSMA PET imaging in prostate cancer", "US 2025: Gozellix kit; selection of patients for PSMA-targeted radioligand therapy" ;
  onco:related <https://onco.cc/drugs/ga68-psma-11/>, <https://onco.cc/drugs/locametz/>, <https://onco.cc/drugs/pylarify/> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/psma-pet/>, <https://onco.cc/technologies/pet-ct/> ;
  onco:targets <https://onco.cc/targets/psma/> ;
  onco:drugs <https://onco.cc/drugs/pluvicto/> ;
  onco:companies <https://onco.cc/companies/telix/> ;
  onco:terms <https://onco.cc/terms/biochemical-recurrence/>, <https://onco.cc/terms/theranostics/> ;
  onco:trials <https://onco.cc/trials/psma-prerp/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-psma-prerp-hope-jama-oncol-2021/> .